SEOUL (Reuters) - South Korean drugmaker Celltrion Inc (KS:068270) aims to set up a joint venture in China within the first half of this year, and begin selling products in the...
By John Miller and Ben Hirschler LONDON/ZURICH (Reuters) - Roche (S:ROG), the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made...
By Natalie Grover and Susan Kelly (Reuters) - Johnson & Johnson (N:JNJ) on Tuesday raised its full-year 2016 sales and earnings forecasts and reported quarterly results that...
Mylan (NASDAQ:MYL): With Neulasta Biosimilar Approval, Focus Moves to Advair and Restasis June 12, 2018 Over the last year, Mylan has faced a difficult generic environment, but has...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||Strong Buy||BUY||Strong Sell||Strong Sell|
|Summary||Strong Buy||Strong Buy||Neutral||Strong Sell||Neutral|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Belt Hold Bullish||1D||Current|
|Three Outside Down||1W||Current|
|Engulfing Bearish||1W||1||Nov 03, 2019|
|Evening Doji Star||1W||1||Nov 03, 2019|
|Doji Star Bearish||1W||2||Oct 27, 2019|
Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical Pharmaceutical segment is involved in the manufacturing and sale of therapeutic drugs for liver disease under the name of Godex, as well as the treatment of autoimmune diseases under the name of Remsima. The Other segment manufactures and sells other generic drugs. The Company distributes its products within the domestic market and to overseas markets.Read More
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.